On March 5th, Innexo BV will open its doors for the first exclusive Acceleration Day of 2026, bringing together over 20 licensed producers from 10 different countries for a focused working session centered on integrated pest and disease management (IPDM) and No-Veg cultivation strategies.
Unlike traditional conferences or trade showcases, Acceleration Day is structured as a closed innovation forum. The event is designed to facilitate in-depth technical exchange, strategic collaboration, and data-driven discussion among decision-makers active in pharmaceutical-grade cannabis production.
© Innexo
A working platform for innovation
The Acceleration Day format is built around practical knowledge exchange and cross-disciplinary integration. Participants include cultivation directors, R&D managers, technology developers, breeders, and regulatory-aware operators.
Alongside licensed producers, strategic platform partners and innovators attending the session include:
· Atami
· Faven (Under Canopy Lighting)
· Bionova Nutrients
· ProGuard
· O3 Tech
· Veha Plastics BV (Dosatron)
· Fluence
· Cannabud.ai
· Medical Resource Association, Inc.
· EmpowHer Cannabis Society
· Avitas Global
· Valenveras
· MMJDaily
The diversity of the group reflects a central theme of the event: integrated system thinking. Rather than addressing cultivation variables in isolation, Acceleration Day emphasizes how lighting strategy, fertigation, biological crop protection, climate control, data analytics, and genetic selection interact within a highly regulated pharmaceutical production environment.
Integrated pest & disease management as a foundational strategy
The central theme of this edition is Integrated Pest & Disease Management (IPDM), approached not as a reactive measure, but as a structural design principle within controlled environment agriculture.
In pharmaceutical cannabis production, reproducibility and compliance are non-negotiable. Pest and pathogen pressure does not only threaten yield; it directly impacts batch consistency, regulatory approval, and economic viability.
During the session, participants will explore:
· Preventative greenhouse and indoor system design
· Biological control strategies within compliant frameworks
· Environmental optimization to reduce disease pressure
· Data-driven monitoring and AI-supported early detection tools
· Cross-border regulatory implications of crop protection strategies
The goal is to move beyond fragmented interventions and toward fully integrated management models aligned with GMP-oriented production.
No-veg cultivation as an efficiency strategy
In addition to IPDM, the event will address No-Veg cultivation strategies. While still emerging within regulated markets, No-Veg approaches aim to reduce cycle time, energy input, and spatial inefficiencies by eliminating or minimizing vegetative phases under certain production models.
Within energy-intensive illuminated systems, particularly in Northern European climates, reducing non-productive input hours has significant operational implications. By combining lighting optimization, cultivar selection, and environmental control strategies, producers are increasingly exploring whether direct-to-flower methodologies can maintain pharmaceutical-grade standards while improving energy performance.
The topic is expected to generate both technical debate and practical case-based discussions among participants.
Expert perspective: Matthew Gates
The program will feature Matthew Gates as the prominent expert speaker. Known for his specialization in cannabis entomology and integrated pest management systems, Gates will contribute insights into pest ecology, monitoring methodologies, and practical IPDM implementation under commercial production conditions.
His contribution is expected to bridge academic understanding and real-world cultivation practice.
© Innexo
From knowledge exchange to industry standard
Acceleration Day is structured around a core principle: knowledge sharing drives innovation; innovation drives standardization; and standardization builds the future of regulated cannabis production.
By convening producers and technology providers in a closed working environment, Innexo aims to accelerate the transition from isolated experimentation to validated, reproducible production frameworks.
Rather than positioning discoveries as marketing claims, the format encourages critical discussion before methodologies scale into broader industry adoption.
As the European medical cannabis sector continues to mature, collaborative forums such as this may play an increasingly important role in shaping technical consensus and operational best practices.
Outcomes and insights from the March 5th session are expected to inform upcoming research collaborations and development trajectories throughout 2026 and beyond.
For more information:
Innexo BV
[email protected]
LinkedIn
innexo.nl
